In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates

Veterinary Dermatology

Volumn 23, Issue 4, 2012, Pages

  Boyen, Filip ^a   Verstappen, Koen M H W ^b   De Bock, Manuelle ^c   Duim, Birgitta ^b   Weese, Jeffrey Scott ^d   Schwarz, Stefan ^e   Haesebrouck, Freddy ^a   Wagenaar, Jaap A ^b  

^a GHENT UNIVERSITY   (Belgium)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Elanco Animal Health   (Belgium)

^d UNIVERSITY OF GUELPH   (Canada)

^e FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MICONAZOLE; POLYMYXIN B;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLASSIFICATION; DOG; DOG DISEASE; DRUG EFFECT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; DOG DISEASES; DOGS; METHICILLIN RESISTANCE; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 84864133290     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01040.x     Document Type: Article

References (31)

1. Devriese LA, Vancanneyt M, Baele M et al. Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int J Syst Evol Microbiol 2005; 55: 1569-1573.
2. Devriese LA, Hermans K, Baele M et al. Staphylococcus pseudintermedius versus Staphylococcus intermedius. Vet Microbiol 2009; 133: 206-207.
3. Cox HU, Hoskins JD, Newman SS et al. Temporal study of staphylococcal species on healthy dogs. Am J Vet Res 1988; 49: 747-751.
4. Talan DA, Staatz D, Staatz A et al. Staphylococcus intermedius in canine gingiva and canine-inflicted human wound infections: laboratory characterization of a newly recognized zoonotic pathogen. J Clin Microbiol 1989; 27: 78-81.
5. Weese JS, van Duijkeren E. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol 2010; 140: 418-429.
6. Riegel P, Jesel-Morel L, Laventie B et al. Coagulase-positive Staphylococcus pseudintermedius from animals causing human endocarditis. Int J Med Microbiol 2011; 301: 237-239.
7. Perreten V, Kadlec K, Schwarz S et al. Clonal spread of methicillin-resistant Staphylococcus pseudintermedius in Europe and North America: an international multicentre study. J Antimicrob Chemother 2010; 65: 1145-1154.
8. Kadlec K, Schwarz S, Perreten V et al. Molecular analysis of methicillin-resistant Staphylococcus pseudintermedius of feline origin from different European countries and North America. J Antimicrob Chemother 2010; 65: 1826-1828.
9. Guardabassi L, Ghibaudo G, Damborg P. In vitro antimicrobial activity of a commercial ear antiseptic containing chlorhexidine and Tris-EDTA. Vet Dermatol 2010; 21: 282-286.
10. Storm DR, Rosenthal KS, Swanson PE. Polymyxin and related peptide antibiotics. Annu Rev Biochem 1977; 46: 723-763.
11. Rosenthal KS, Storm DR. Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxinB. J Antibiot (Tokyo) 1977; 30: 1087-1092.
12. Schwartz SN, Medoff G, Kobayashi GS et al. Antifungal properties of polymyxinB and its potentiation of tetracycline as an antifungal agent. Antimicrob Agents Chemother 1972; 2: 36-40.
13. Van den Bossche H, Willemsens G, Cools W et al. Biochemical effects of miconazole on fungi II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem Biol Interact 1978; 21: 59-78.
14. Nobre LS, Todorovic S, Tavares AF et al. Binding of azole antibiotics to Staphylococcus aureus flavohemoglobin increases intracellular oxidative stress. J Bacteriol 2010; 192: 1527-1533.
15. Engelen M, De Bock M, Hare J et al. Effectiveness of an otic product containing miconazole, polymyxinB and prednisolone in the treatment of canine otitis externa: multi-site field trial in the US and Canada. Int J Appl Res Vet Med 2010; 8: 21-30.
16. Hariharan H, McPhee L, Heaney S et al. Antimicrobial drug susceptibility of clinical isolates of Pseudomonas aeruginosa. Can Vet J 1995; 36: 166-168.
17. Vannuffel P, Gigi J, Ezzedine H et al. Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol 1995; 33: 2864-2867.
18. Khanna T, Friendship R, Dewey C et al. Methicillin resistant Staphylococcus aureus colonization in pigs and pig farmers. Vet Microbiol 2008; 128: 298-303.
19. Bannoehr J, Franco A, Iurescia M et al. Molecular diagnostic identification of Staphylococcus pseudintermedius. J Clin Microbiol 2009; 47: 469-471.
20. Nienhoff U, Kadlec K, Chaberny IF et al. Transmission of methicillin-resistant Staphylococcus aureus strains between humans and dogs: two case reports. J Antimicrob Chemother 2009; 64: 660-662.
21. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) website. Available at: Accessed 15 April 2011.
22. CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard, 3rd edition. M31-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008; 24-35.
23. Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev 2007; 20: 391-408.
24. CLSI. Generation, Presentation and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report. Document X-08. Wayne, PA: Clinical and Laboratory Standards Institute, 2011; 5-9.
25. Ruscher C, Lübke-Becker A, Wleklinski CG et al. Prevalence of methicillin-resistant Staphylococcus pseudintermedius isolated from clinical samples of companion animals and equidaes. Vet Microbiol 2009; 136: 197-201.
26. Nienhoff U, Kadlec K, Chaberny IF et al. Methicillin-resistant Staphylococcus pseudintermedius among dogs admitted to a small animal hospital. Vet Microbiol 2011; 150: 191-197.
27. Sud IJ, Feingold DS. Action of antifungal imidazoles on Staphylococcus aureus. Antimicrob Agents Chemother 1982; 22: 470-474.
28. Pietschmann S, Hoffmann K, Voget M et al. Synergistic effects of miconazole and polymyxinB on microbial pathogens. Vet Res Commun 2008; 33: 489-505.
29. Jones BM, Geary I, Lee ME et al. Comparison of the in vitro activities of fenticonazole, other imidazoles, metronidazole, and tetracycline against organisms associated with bacterial vaginosis and skin infections. Antimicrob Agents Chemother 1989; 33: 970-972.
30. van der Linden DS, Short D, Dittmann A et al. Synergistic effects of ovine-derived cathelicidins and other antimicrobials against Escherichia coli O157:H7 and Staphylococcus aureus 1056 MRSA. Biotechnol Lett 2009; 31: 1265-1267.
31. Quinn P, Carter M, Markey B et al. (1994) Staphylococcus species. In: Clinical Veterinary Microbiology, 1st edition. Edinburgh, Mosby: 125.